Skov K A
Advanced Therapeutics, BC Cancer Research Centre, 601 W. 10th Ave., Vancouver, BC, Canada.
Mutat Res. 1999 Dec 6;430(2):241-53. doi: 10.1016/s0027-5107(99)00136-0.
The rationale for and importance of research on effects after radiation at "low doses" are outlined. Such basic radiobiological studies on induction of repair enzymes, protective mechanisms, priming, and hypersensitivity are certainly all relevant to treatment of cancer (see Section 1, Studies at low doses - relevance to cancer treatment). Included are examples from many groups, using various endpoints to address the possibility of an induced resistance, which has been compared to the adaptive response [M.C. Joiner, P. Lambin, E.P. Malaise, T. Robson, J.E. Arrand, K.A. Skov, B. Marples, Hypersensitivity to very low single radiation doses: its relationship to the adaptive response and induced radioresistance, Mutat. Res. 358 (1996) 171-183.]. This is not intended to be an exhaustive review--rather a re-introduction of concepts such as priming and a short survey of molecular approaches to understanding induced resistance. New data on the response of HT29 cells after treatment (priming) with co-cultured activated neutrophils are included, with protection against X-rays (S1). Analysis of previously published results in various cells lines in terms of increased radioresistance (IRR)/intrinsic sensitivity are presented which complement a study on human tumour lines [P. Lambin, E.P. Malaise, M.C. Joiner, Might intrinsic radioresistance of human tumour cells be induced by radiation?, Int. Radiat. Biol. 69 (1996) 279-290].It is not feasible to extrapolate to low doses from studies at high doses. The biological responses probably vary with dose, LET, and have variable time frames. The above approaches may lead to new types of treatment, or additional means to assess radioresponsiveness of tumours. Studies in many areas of biology would benefit from considerations of different dose regions, as the biological responses vary with dose. There may also be some implications in the fields of radiation protection and carcinogenesis, and the extensions of concepts of hyper-radiosensitivity (HRS)/IRR extended to radiation exposure are considered in Section 2, Possible relevance of IRR concepts to radiation exposure (space). More knowledge on inducible responses could open new approaches for protection and means to assess genetic predisposition. Many endpoints are used currently--clonogenic survival, mutagenesis, chromosome aberrations and more direct--proteins/genes/functions/repair/signals, as well as different biological systems. Because of scant knowledge of the relevant aspects at low doses, such as inducible/protective mechanisms, threshold, priming, dose-rate effects, LET within one system, it is still too early to draw conclusions in the area of radiation exposure. Technological advances may permit much needed studies at low doses in the areas of both treatment and protection.
本文概述了“低剂量”辐射后效应研究的基本原理和重要性。此类关于修复酶诱导、保护机制、预激和超敏反应的基础放射生物学研究无疑都与癌症治疗相关(见第1节,低剂量研究——与癌症治疗的相关性)。文中列举了许多研究小组的实例,他们采用各种终点指标来探讨诱导抗性的可能性,并将其与适应性反应进行了比较[M.C. 乔伊纳、P. 兰宾、E.P. 马莱塞、T. 罗布森、J.E. 阿兰、K.A. 斯科夫、B. 马普尔斯,对极低单次辐射剂量的超敏反应:其与适应性反应和诱导抗辐射性的关系,《突变研究》358 (1996) 171 - 183]。本文并非详尽的综述——而是对预激等概念的重新引入,以及对理解诱导抗性的分子方法的简要概述。文中纳入了共培养活化中性粒细胞处理(预激)后HT29细胞的反应新数据,以及对X射线的抗性(S1)。本文还分析了先前在各种细胞系中发表的关于辐射抗性增加(IRR)/内在敏感性的结果,这些结果补充了一项关于人类肿瘤细胞系的研究[P. 兰宾、E.P. 马莱塞、M.C. 乔伊纳,辐射能否诱导人类肿瘤细胞的内在抗辐射性?,《国际辐射生物学》69 (1996) 279 - 290]。从高剂量研究推断低剂量情况是不可行的。生物反应可能随剂量、传能线密度(LET)变化,且具有不同的时间框架。上述方法可能会带来新型治疗方法,或评估肿瘤放射反应性的额外手段。生物学许多领域的研究将受益于对不同剂量区域的考虑,因为生物反应随剂量而异。这在辐射防护和致癌作用领域可能也有一些启示,第2节将探讨IRR概念扩展到辐射暴露(太空)的可能相关性。关于可诱导反应的更多知识可能会为防护开辟新途径,并提供评估遗传易感性的手段。目前使用了许多终点指标——克隆形成存活、诱变、染色体畸变以及更直接的指标——蛋白质/基因/功能/修复/信号,还有不同的生物系统。由于对低剂量相关方面,如可诱导/保护机制、阈值、预激、剂量率效应、一个系统内的LET了解不足,在辐射暴露领域得出结论仍为时过早。技术进步可能使治疗和防护领域急需的低剂量研究成为可能。